Small bowel adenocarcinoma metastatic to the ovaries in a 12-year-old girl

J Pediatr Hematol Oncol. 1998 Sep-Oct;20(5):498-501. doi: 10.1097/00043426-199809000-00019.

Abstract

Purpose: Small bowel adenocarcinoma is a rare cancer and usually occurs in elderly males. A 12-year-old girl with metastatic small bowel adenocarcinoma and her clinical course are described. The difficulties in making the pathologic diagnosis and the literature are also reviewed.

Patients and methods: A 12-year-old girl had partial small bowel obstruction and bilateral ovarian enlargement. Exploratory laparotomy revealed a jejunal tumor with bilateral ovarian involvement and extensive peritoneal and pelvic studding. The pathologic diagnosis of small bowel adenocarcinoma was made.

Results: The patient had a moderate response to therapy with 5-fluorouracil, leucovorin, and alpha-interferon before developing progressive disease unresponsive to therapy with topotecan, taxol, or carboplatin. She survived for 23 months after diagnosis.

Conclusion: Making an accurate diagnosis of tumors metastatic to the ovary can be difficult and requires attention to histologic detail. Small bowel adenocarcinoma is usually a chemoresistant tumor with extremely poor outcome. This patient had a moderate response to chemotherapy and a prolonged survival compared to that of patients previously reported.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma* / drug therapy
  • Adenocarcinoma* / pathology
  • Adenocarcinoma* / physiopathology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Child
  • Female
  • Fluorouracil / therapeutic use
  • Humans
  • Interferon-alpha / therapeutic use
  • Intestinal Neoplasms* / drug therapy
  • Intestinal Neoplasms* / pathology
  • Intestinal Neoplasms* / physiopathology
  • Intestine, Small / pathology
  • Leucovorin / therapeutic use
  • Ovarian Neoplasms* / drug therapy
  • Ovarian Neoplasms* / physiopathology
  • Ovarian Neoplasms* / secondary

Substances

  • Interferon-alpha
  • Leucovorin
  • Fluorouracil